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Abstract: Endolysosomal processing has a critical influence on immunogenicity as well as immune
polarization of protein antigens. In industrialized countries, allergies affect around 25% of the
population. For the rational design of protein-based allergy therapeutics for immunotherapy,
a good knowledge of T cell-reactive regions on allergens is required. Thus, we sought to analyze
endolysosomal degradation patterns of inhalant allergens. Four major allergens from ragweed, birch,
as well as house dust mites were produced as recombinant proteins. Endolysosomal proteases were
purified by differential centrifugation from dendritic cells, macrophages, and B cells, and combined
with allergens for proteolytic processing. Thereafter, endolysosomal proteolysis was monitored by
protein gel electrophoresis and mass spectrometry. We found that the overall proteolytic activity of
specific endolysosomal fractions differed substantially, whereas the degradation patterns of the four
model allergens obtained with the different proteases were extremely similar. Moreover, previously
identified T cell epitopes were assigned to endolysosomal peptides and indeed showed a good
overlap with known T cell epitopes for all four candidate allergens. Thus, we propose that the
degradome assay can be used as a predictor to determine antigenic peptides as potential T cell
epitopes, which will help in the rational design of protein-based allergy vaccine candidates.
Keywords: allergen proteolysis; Bet v 1; Amb a 1; Der p 1; Der p 2; proteases from dendritic cells;
proteases from macrophages; proteases from B cells; degradome assay
1. Introduction
Over a decade ago, Delamarre et al. suggested that differential processing of antigens in lysosomal
compartments may directly influence the quality of the subsequent immune response [1]. In general,
antigenic peptides can be presented either on major histocompatibility complex (MHC) class I or
class II molecules to CD8+ or CD4+ T cells, respectively. MHCI molecules are found on almost all
cell types and present peptides derived from intracellular antigens, whereas MHCII complexes are
constitutively expressed only on professional antigen-presenting cells (APCs) and primarily display
extracellular antigens [2]. Professional APCs include dendritic cells (DCs), B cells, macrophages, and
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thymic epithelial cells, the latter playing a central role in controlling T cell development and T cell
tolerance [3,4]. MHCII molecules are assembled with a chaperone protein called the invariant chain
(Ii) in the endoplasmic reticulum, which is trimmed and cleaved in the endosome where the residual
part of the invariant chain (CLIP) is ultimately replaced by antigenic peptides—a process regulated by
HLA-DM (human leukocyte antigen DM) [2]. For antigen uptake, APCs use different mechanisms
such as macropinocytosis, receptor-mediated endocytosis, or phagocytosis to internalize extracellular
material into vesicles where antigen processing is initiated. Of note, 20–30% of antigenic peptides
eluted from MHCII molecules have an intracellular origin and are transferred to endolysosomal
compartments via mechanisms of autophagy [3]. Following internalization, antigens are proteolytically
processed in endolysosomal compartments and thereafter loaded on the MHCII complex and presented
to T cells, which eventually initiate T cell activation. This process is fundamental for the development
of an adaptive immune response.
To date, 25% of the population in industrialized countries are affected by allergies, whereas
allergen immunotherapy based on formulated allergen extracts represents the only treatment option,
which may eventually modify the cause of the disease. However, the use of allergen extracts for
therapeutic interventions is a matter of controversy, which led to the suggestion of replacing extracts
with purified allergens or allergen epitopes [5]. Yet, the design of allergy vaccines requires a good
knowledge of B as well as T cell-reactive regions on the allergenic molecules. Antibody epitope
mapping strategies are applied to identify B cell epitopes, whereas the identification of T cell epitopes
is primarily achieved by proliferation assays using short overlapping peptides covering the entire
sequence of the allergen [5,6]. In addition, an in vitro assay has been developed that mimics the
natural proteolytic processing of allergens in the endolysosomal compartments of APCs. For the
assay, a cocktail of proteases isolated from a murine DC line is combined with allergenic proteins and
protein degradation is monitored by mass spectrometry. The authors suggested that this protease mix
could be applied as a surrogate for human DC-derived proteases to identify T cell-reactive regions on
allergens [7]. In fact, a study with the major birch pollen allergen Bet v 1 demonstrated that the in vitro
generated Bet v 1-derived peptides showed a precise overlap with naturally processed T cell-reactive
peptides isolated from DCs as well as peptides obtained from T cell epitope mapping of Bet v 1 [8,9].
We therefore sought to compare the degradation pattern of proteases isolated from different APCs,
i.e., macrophages, B cells, and DCs. Four different major inhalant allergens from ragweed (Amb a 1)
and birch pollen (Bet v 1), as well as house dust mites (Der p 1 and 2) were selected and produced as
recombinant proteins. Thereafter, the allergens were combined with endolysosomal proteases, whereas
proteolysis was monitored by protein gel electrophoresis and mass spectrometry. Moreover, we tested
whether the activation of APCs with bacterial endotoxin had an influence on the proteolytic pattern
or speed.
2. Results
2.1. Expression and Purification of Recombinant Allergens
The major inhalant allergens Bet v 1 from birch, Amb a 1 from ragweed, as well as proDer p 1
and Der p 2 from house dust mites were produced either in E. coli (Bet v 1 and Der p 2) or P. pastoris
(Amb a 1 and proDer p 1). As Der p 2 has three internal disulphide bonds, an E. coli strain capable
of forming cysteine bonds in the bacterial cytoplasm was selected. The correct formation of cysteine
bonds was verified by mass spectrometry (data not shown). On SDS-PAGE, the band of proDer p 1
appeared blurry as the protein is hypermannosylated and therefore not migrating as a homogenous
specimen. All recombinant allergens were purified to homogeneity (Figure 1a) and characterized
physicochemically prior to degradation analyses (data not shown).
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Figure 1. (a) 15% SDS-PAGE of purified allergens; 1 μg recombinant proteins were loaded per lane; 
(b) The protease activity of endolysosomal fractions was determined using the fluorescent substrate 
Z-Phe-Arg-AMC. 
2.2. Subcellular Fractionation of Endolysosomes and Characterization of Proteolytic Activity 
Endolysosomes were isolated by differential centrifugation from three different APC cell lines, 
i.e., A20 B cells, JAWSII DCs, and RAW 264.7 macrophages, respectively. Total protein content was 
determined by Bradford assays. From 2 × 107 cells, we obtained 630 μg of JAWSII, 165 μg of RAW 
264.7, and 99 μg of A20 endolysosomal proteins. To investigate whether the activation status of APCs 
could influence the proteolytic activity, we stimulated RAW 264.7 cells with bacterial endotoxin (LPS) 
for 24 h. Thereafter, cells were harvested and counted. Indeed, the total endolysosomal protein 
content of RAW 264.7 increased to 270 μg/2 × 107 cells after activation. 
To determine the relative proteolytic activity of endolysosomal proteases, we used the substrate 
Z-Phe-Arg-AMC, which can be cleaved by cysteine proteases, i.e., cathepsin B, F, K, L, and S, to a 
fluorescent product [10,11]. RAW 264.7 macrophages displayed the highest proteolytic activity using 
this substrate, followed by JAWSII- and A20-derived endolysosomal proteases. The relative 
proteolytic activity of RAW 264.7 proteases was 6.3 times higher than the activity of endolysosomal 
proteases from JAWSII cells and 956 times higher than the activity of A20, whereas the difference 
between JAWSII and A20 was a factor of 151 (Figure 1b). However, there was no difference in 
proteolytic activity between resting and activated RAW 264.7 cells (0.059 vs. 0.056 mM). 
2.3. Endolysosomal Degradations of Inhalant Allergens 
For proteolytic processing of inhalant allergens, 7.5 arbitrary units of JAWSII- as well as RAW 
264.7-derived endolysosomal proteases were applied for each degradation, whereas we used 0.01 
arbitrary units of A20 proteases. This was necessary, as the endolysosomal A20 proteins showed a 
very low proteolytic activity/μg and as the amount of proteins could not have been increased without 
increasing the volume of the degradome samples substantially. Degradations were performed in a 
time-dependent manner under reducing conditions at 37 °C and a pH of 4.8. Reactions were stopped 
by heat inactivation of the protease/allergen mixture [7]. The low pH is intended to resemble the pH 
value of late endosomes [12]. Subsequently, 10 μL aliquots of the degraded samples were analyzed 
by SDS-PAGE and the decrease of intact protein was measured densitometrically (Figure 2). Bet v 1 
was very efficiently degraded by JAWSII proteases. After 6 h, 70% of the intact protein had already 
been processed, whereas for RAW 264.7 after 6 h, 80% of Bet v 1 remained still intact and for A20 we 
could hardly determine any degradation of the protein. Amb a 1 was efficiently degraded by JAWSII 
(58% degradation after 6 h), and to a lesser extent by RAW 264.7 (48% degradation after 6 h) and A20 
(27% degradation after 6 h). The recombinant dust mite allergen proDer p 1, a hypermannosylated 
glycoprotein stabilized by three intermolecular disulphide bridges, [13], was found to be very 
resistant to endolysosomal proteolysis (>80% intact protein after 24 h for JAWSII and A20). 
Surprisingly, digestions with RAW 264.7 proteases resulted in approximately 60% degradation of 
Figure 1. (a) 15% SDS-PAGE of purified allergens; 1 µg recombinant proteins were loaded per
lane; (b) The protease activity of endolysosomal fractions was determined using the fluorescent
substrate Z-Phe-Arg-AMC.
2.2. Subcellular Fractionation of Endolysosomes and Characterization of Proteolytic Activity
Endolysos mes were isolated by differential ce trif ati fro three different APC cell lines,
i.e., A20 B cells, JAWSII DCs, and RAW 264.7 macropha , ti ely. Total protein content was
determined by Bradford assays. From 2 × 7 lls, e obtained 630 µg of JAWSII, 165 µg of RAW
264.7, and 99 µg of A20 endolysosomal proteins. To investi r the activation status of APCs
could influence the proteolytic activity, we stimulated . lls ith bacterial end toxin (LPS)
for 24 h. T ereafter, cells were harvested an counted. Indeed, the total endolysos mal protein c ntent
of RAW 264.7 increased to 270 µg/2 × 107 cells after activation.
To determine the relative proteolytic activity of endolysosomal proteases, we used the substrate
Z-Phe-Arg-AMC, which can be cleaved by cysteine proteases, i.e., cathepsin B, F, K, L, and S, to a
fluorescent product [10,11]. RAW 264.7 macrophages displayed the highest proteolytic activity using
this substrate, followed by JAWSII- and A20-derived endolysosomal proteases. The relative proteolytic
activity of RAW 264.7 proteases was 6.3 times higher than the activity of endolysosomal proteases from
JAWSII cells and 956 times higher than the activity of A20, whereas the difference between JAWSII and
A20 was a factor of 151 (Figure 1b). However, there was no difference in proteolytic activity between
resting and activated RAW 264.7 cells (0.059 vs. 0.056 mM).
2.3. Endolysosomal Degradations of Inhalant Allergens
For proteolytic processing of inhalant allergens, 7.5 arbitrary units of JAWSII- as well as RAW
264.7-derived endolysosomal proteases were applied for each degradation, whereas we used 0.01
arbitrary units of A20 proteases. This was necessary, as the endolysosomal A20 proteins showed
a very low proteolytic activity/µg and as the amount of proteins could not have been increased
without increasing the volume of the degradome samples substantially. Degradations were performed
in a time-dependent manner under reduci g conditions at 37 ◦C and a pH of 4.8. Reactions were
stopped by heat i activation of the protease/allergen mixture [7]. Th low pH is intend d to resemble
the pH value of l te endosomes [12]. Subsequently, 10 µL aliquot of the degraded samples were
analyzed b SDS-PAGE and the decrease of intact protein was measured densi ome r cally (Figure 2).
Bet v 1 was very effici ntly degraded by JAWSII proteases. After 6 h, 70% of the intact prot in
had already been processed, whereas for RAW 264.7 after 6 h, 80% of Bet v 1 remained still intact
and for A20 we could hardly determine any degradation of the protein. Amb a 1 was efficiently
degraded by JAWSII (58% degradation after 6 h), and to a lesser extent by RAW 264.7 (48% degradation
after 6 h) and A20 (27% degradation after 6 h). The recombinant dust mite allergen proDer p 1,
a hypermannosylated glycoprotein stabilized by three intermolecular disulphide bridges, [13], was
found to be very resistant to endolysosomal proteolysis (>80% intact protein after 24 h for JAWSII and
A20). Surprisingly, digestions with RAW 264.7 proteases resulted in approximately 60% degradation
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of proDer p 1 after 24 h. Though the dust mite allergen Der p 2 is not glycosylated, this 14 kDa protein
has also three intramolecular disulphide bridges stabilizing the predominantly beta-sheet structure of
the allergen [14]. Thus, in our experimental setup we could hardly measure any decrease in intact Der
p 2 over time with any of the three endolysosomal fractions used.
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2.4. Activated Macrophages Display Identical Proteolysis Pattern as Resting Cells
Compared to resting cells, activated macrophages showed a very similar activity pattern (Figure 2).
Endolysosomal enzymes from activated as well as resting macrophages degraded Bet v 1 and Amb
a 1 rather slowly (both allergens showed approx. 40% degradation for either cell line after 24 h),
whereas proDer p 1 was degraded efficiently (approx. 60% degradation for either activated or resting
macrophages after 24 h). Again, Der p 2 showed hardly any reduction of intact protein.
2.5. Mass Spectrometric Analyses of Degradation Patterns Revealed No Differences Between Cell Lines
We compared the degradation patterns of all four inhalant allergens processed with
endolysosomal enzymes from different cell lines, as well as proteases from activated and resting
macrophages at two time points (6 and 24 h) (Figure 3 and Figure S1). For Bet v 1, we found that
after 6 h most peptides were produced by JAWSII proteases. Though we did not observe a substantial
decrease in intact Bet v 1, we also obtained almost the same amount of different peptides with the
A20 protease fraction as with JAWSII cells. The peptide patterns of activated and resting RAW 264.7
appeared to be identical. After 24 h of proteolysis, the patterns between the cell lines did not change,
although we found differences in the number of peptides detected for each cell line.
For Amb a 1 the picture was similar and we obtained conserved peptide stacks for each time
point. After 6 h most peptides were acquired from JAWSII degradations, whereas after 24 h the A20
proteases produced a large amount of antigenic peptides. Again, we could not find any difference
between activated and resting macrophages. Despite the fact that macrophage-derived proteases were
more efficient in degrading proDer p 1, we found very similar peptide patterns after 6 and 24 h for all
cell lines and activation states. For Der p 2 we hardly observed any degradation of full-length protein
on SDS-PAGE. The degradation patterns were virtually identical, independent of the protease source.
In general, proteolytic digestions of proDer p 1 and Der p 2 resulted in less potentially T cell-reactive
peptides compared to proteolysis of Bet v 1 or Amb a 1; however, we also found peptide stacks for
these proteolytically stable allergens. Natural Der p 1 is synthesized in mites as an inactive pre-pro
enzyme (pre-proDer p 1), which has to undergo maturation leading to full proteolytically active
Der p 1 [15]. As we used proDer p 1 for our degradome experiments, we found that the propeptide
was, in general, less stable than the covalently linked mature allergen; thus we obtained more peptides
from this part of the recombinant protein. Nevertheless, we also measured peptides derived from the
sequence of mature Der p 1. Of note, at an acidic pH (pH 4), the unfolding of the propeptide is initiated
followed by a multi-step auto-degradation catalyzed by Der p 1 itself, which eventually leads to the
maturation of the allergen under reducing conditions [16]. Recently, it was demonstrated that at pH
4.8 the autocatalytic processing of unglycosylated proDer p 1 (N16pQ/N52Q) reached only 20% of the
maturation observed at pH 4. Moreover, the full-length wild-type recombinant propeptide produced in
E. coli (unglycosylated, equivalent to N16pQ) could not be hydrolyzed by Der p 1 at pH 4.8 but only at
pH 4 [17]. In our study, we evaluated the endolysosomal degradation of glycosylated wild type proDer
p 1. We cannot fully exclude that residual auto-maturation of Der p 1 occurs under our experimental
conditions. However, the presence of glycosylations and particularly glycan residues present in the
propeptide structure negatively influences the maturation process of proDer p 1 [18]. Thus, only a very
limited amount of active Der p 1 can be generated, which could also degrade endolysosomal proteases.
However, we do not have evidence that this could explain the low levels of Der p 1 degradation seen
in our assays.
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asparaginyl endopeptidase (AEP) in a dominant T cell epitope, thus the presentation of this specific
epitope inversely correlates with the expression of the protease [21].
The majority of endolysosomal proteases belong to the aspartyl and cysteine protease families
of endo- and/or exopeptidases [7]. In fact, the expression patterns of endolysosomal proteases seem
variable and cell type-specific, as it has been reported that APCs differ significantly in their ability to
degrade antigens. For instance, macrophages express substantially higher amounts of endolysosomal
proteases compared to B cells or DCs [1]. This could also imply that cell line-derived APCs could
have different protease expression patterns than in vivo isolated cells. However, in a study published
in 2011, Egger et al. demonstrated that JAWSII cells contained all important proteases necessary for
antigen processing [7]. Therefore, they compared the proteomes of microsomal fractions isolated from
the murine DC cell line JAWSII with murine bone marrow- as well as human blood-derived DCs by
mass spectrometry. Moreover, they performed degradome assays of multiple different antigens using
proteases from these three sources and found no differences in the proteolytic activity. In the end, the
authors managed to develop a straightforward and scalable assay mimicking the complex events of
proteolysis within endolysosomal compartments based on cell line-derived microsomes. Based on
these findings, we sought to compare the proteolytic pattern of different APCs (macrophages, DCs,
and B cells) from well-established cell lines using a panel of four major inhalant allergens from pollen
as well as dust mites. First, we isolated endolysosomal fractions of different APCs and compared the
proteolytic activity using the substrate Z-Phe-Arg-AMC, which is specific for cysteine cathepsins [22].
As mentioned, cysteine proteases depict a major proportion of all endolysosomal proteases, thus the
cysteine protease activity was used as a surrogate to determine the activity of endolysosomal proteases.
We found that macrophages showed the highest proteolytic activity, followed by DCs and B cells
with by far the lowest activity in this assay. We also compared the proteolytic activity of activated vs.
resting macrophages and, when normalized to the total protein concentration, we could not measure
any difference in the proteolytic activity. However, the total amount of endolysosomal proteins of
activated macrophages was almost twice as high as that from resting cells. Thereafter, we performed
degradation studies to compare the proteolysis pattern of DCs, B cells, as well as activated and resting
macrophages. The degradation patterns were analyzed by mass spectrometry and identified peptides
were assigned to sequence areas of the respective allergen. Despite minor differences in the processing
of the four model allergens, the overall degradation patterns were extremely similar. Moreover, there
was no difference between resting and activated cells in terms of proteolysis pattern. This indicates
that the protein structure rather than the source of endolysosomal proteases determined the fate of the
allergens in our study. The finding also supports the idea that antigen processing can be studied with
endolysosomal proteases isolated from a single cell line.
As proteolytically processed antigens represent the source material for T cell-reactive peptides, we
further investigated whether the allergen peptides would match previously identified T cell epitopes
(Figure 3) [23–32]. Despite the fact that the pollen allergens Bet v 1 and Amb a 1 are processed rapidly,
whereas the mite allergens Der p 1 and Der p 2 are degraded slowly, we found a very good overlap of
the proteolytically processed peptides with known T cell epitopes for all four candidate allergens.
As natural allergens often represent heterogeneous mixtures of multiple isoforms [33–36], which
cannot easily be separated by chromatographic procedures, we restricted ourselves to the use of
well-characterized recombinant allergens. Therefore, the assignment of processed peptides to a unique
protein sequence becomes feasible, which allowed the exact determination of degradation patterns.
We propose that the degradome assay can be used as a predictor to determine antigenic peptides as
potential T cell epitopes. Moreover, the method is independent of the APC cell line used for harvesting
the endolysosomal proteases. Therefore, the method could not only be a valuable tool to determine the
immunogenicity of allergens but also to predict T cell-reactive epitopes on allergenic proteins [1,7,9].
This shall help in the rational design of candidate molecules for allergen immunotherapy in the future.
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4. Materials and Methods
4.1. Production of Recombinant Allergens
The birch pollen allergen Bet v 1.0101, termed Bet v 1 throughout the manuscript, was produced
as recombinant protein in E. coli and purified to homogeneity [9].
The ragweed allergen Amb a 1.0305, termed Amb a 1 above, was supplied by Biomay AG,
Vienna, Austria. The protein was expressed in P. pastoris and purified from culture supernatants using
a two-step chromatographic procedure.
A stable pro form of the allergenic cysteine protease Der p 1 from the house dust mite species
Dermatophagoides pteronyssinus was produced in P. pastoris as previously described [13]. In brief, proDer
p 1.0102, termed proDer p 1 throughout the manuscript, was expressed and secreted into the culture
medium. The purification from the supernatant was performed by anion-exchange chromatography
at pH 9.0. Fractions containing proDer p 1 were pooled, concentrated, and a polishing step was
performed by gel filtration chromatography.
The dust mite allergen Der p 2.0103, termed Der p 2 throughout the manuscript, was produced in
E. coli. Therefore, a synthetic gene of Der p 2, obtained by ATG Biosynthetics, Merzhausen, Germany,
was cloned into the pET28b vector system. Subsequently, bacteria were transformed and the protein
was expressed at 37 ◦C. After harvesting the cells, Der p 2 was extracted from the lysate in 50 mM Tris
pH 8.5 and 0.5 M urea. Following acidic precipitation at pH 4.0, the allergen-containing supernatant
was loaded onto an SP-FF column (GE Healthcare, Little Chalfont, UK) and purified with a gradient to
50 mM Tris pH 4.0, 0.5 M urea, and 0.5 M NaCl.
All proteins were either lyophilized or frozen in appropriate buffers and stored at −20 ◦C.
4.2. Cell Culture
The B cell line A20 (ATCC® TIB-208™) was cultured in RPMI-1640, and supplemented with 10%
FCSi, 50,000 U penicillin, 50 mg streptomycin, 2 mM L-glutamine, 25 mM HEPES, 2.5 mM Na-pyruvate
(all PAN-Biotech GmbH, Aidenbach, Germany), and 50 µM β-mercaptoethanol. Sub-culturing was
performed at 5% CO2 and 37 ◦C according to ATCC guidelines [37]. In brief, cells were harvested by
centrifugation at 250 g for 5 min; after the aspiration of the supernatant, the cells were expanded in
double the volume of fresh medium.
The macrophage cell line RAW 264.7 (ATCC® TIB-71™) [38] was cultured in DMEM (Dulbecco´s
Modified Eagle Medium) high glucose, and supplemented with 5% FCSi, 50,000 U penicillin, 50 mg
streptomycin, 2 mM L-glutamine, 10 mM HEPES, 1 mM Na-pyruvate (all PAN-Biotech GmbH), and
50 µM β-mercaptoethanol. After carefully removing the adherent cells from the bottom of the flask,
all cells were harvested by centrifugation at 250 g for 5 min. RAW 264.7 cells were sub-cultured at
a ratio of 1:5 once per week. The activation of RAW 264.7 cells was performed by the addition of
100 ng/mL lipopolysaccharide (Sigma, St. Louis, MO, USA) to the culture medium for 24 h.
The dendritic cell line JAWSII (ATCC® CRL11908™) was cultured in MEM (Minimum Essential
Medium) α-modification with L-glutamine, and supplemented with 15% FCSi, 1 mM Na-pyruvate
(all PAN-Biotech GmbH), and 5% GM-CSF supernatant [7]. Cell cultures were performed according to
ATCC instructions and as previously described [39].
4.3. Endolysosomal Fractionation
The endolysosomal protein fractions of different cell lines were obtained by differential
centrifugation as previously described [1,7]. In brief, 1 × 108 A20, or 2 × 107 RAW 264.7 and JAWSII
cells, respectively, were resuspended after two washing steps in 5 mL with 250 mM sucrose, 10 mM
Tris-acetate, with a pH of 7.0, disrupted using a Dounce glass tissue grinder, and centrifuged for 10 min
at 6000× g. Thereafter, the supernatant was centrifuged for 1 h at 100,000× g and the resulting pellet
was resuspended in 150 µL with 250 mM sucrose, 10 mM Tris-acetate, with a pH of 7.0. Endolysosomal
proteases were released by five repeated freeze/thaw cycles in liquid nitrogen and at 37 ◦C, respectively,
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and stored at −70 ◦C. The total protein concentration of endolysosomal fractions was determined by
Bradford assay [40].
4.4. Determination of Proteolytic Activity
The protease activity of the endolysosomal fraction of each cell line was determined using the
fluorescent substrate Z-Phe-Arg-AMC (Bachem Holding GmbH, Budendorf, Switzerland), which can
be cleaved by cysteine proteases, i.e., cathepsin B, F, K, L, and S [10,11]. Therefore, endolysosomal
proteases were serially diluted in 10 mM citrate buffer with a pH of 4.8, 0.2 mM dithiothreitol (DTT),
supplemented with 50 µM Z-Phe-Arg-AMC, and relative fluorescent units were determined at an
excitation wavelength of 380 nm and an emission wavelength of 460 nm using a Tecan Infinite M200
plate reader (Tecan Austria GmbH, Grödig, Austria). Results were plotted as RFUs (relative fluorescent
units) at a given concentration. The relative proteolytic activity of endolysosomal fractions was
calculated as the protein concentration required to obtain 5000 RFUs.
4.5. Degradation Assays
After assessing the proteolytic activity of the endolysosomal fractions of the different cell lines,
degradation assays were performed as described [7]. Briefly, 5 µg protein were mixed with 7.5 µg
JAWS II, 15 µg A20, or 1.2 µg RAW 264.7 endolysosomal proteases, respectively, in a volume of 20 µL
with 10 mM citrate buffer with a pH of 4.8, 0.2 mM dithiothreitol. Reactions were incubated at 37 ◦C
and stopped after 0, 1, 3, 6, 12, 24, 48, and 72 h, by denaturation at 95 ◦C for 5 min. Samples were
stored at−20 ◦C and degradation profiles were analyzed by SDS-PAGE. After staining with Coomassie
Brilliant Blue R-250, SDS-gels were evaluated using the Bio-Rad Chemidoc™ MP Imaging System and
the Bio-Rad Image Lab Software (Bio-Rad, Hercules, CA, USA).
4.6. Mass Spectrometry
Samples digested with endolysosomal proteases were desalted using C18 ZipTips (EMD Millipore,
Billerica, MA, USA). Resulting peptides were separated by reverse-phase nano-HPLC (Dionex Ultimate
3000, Thermo Fisher Scientific, Bremen, Germany, column: PepSwift Monolithic Nano Column, 100 µm
× 25 cm, Dionex), where the column was eluted with an acetonitrile gradient (Solvent A: 0.1% (v/v)
FA/0.01% (v/v) TFA/5% (v/v) ACN; solvent B: 0.1% (v/v) FA/0.01% (v/v) TFA/90% (v/v) ACN; 5–45% B
in 60 min) at a flow rate of 1 µL/min at 55 ◦C. The peptides were analyzed by a Q Exactive Orbitrap
mass spectrometer (Thermo Fisher Scientific) directly coupled to the HPLC. Capillary voltage at the
nano-electrospray head was 2 kV. The instrument was tuned for maximum sensitivity. For peptide
assignments, a top 12 method was used with the normalized fragmentation energy at 27%. Survey
and fragment spectra were analyzed with Proteome Discoverer version 1.4 with SequestHT as search
engine (Thermo Fisher Scientific) or PEAKS Studio 8 (Bioinformatics Solutions, Waterloo, ON, Canada),
respectively. Searches were conducted with single allergen sequences. Only peptides with high
confidence scores (XCorr ≥ 2.3 for SequestHT, −10lgP ≥ 35 for PEAKS) were considered.
5. Conclusions
In the present study, endolysosomal processing of major inhalant allergens was studied in vitro.
Therefore, proteases were isolated from DCs, macrophages, and B cells, respectively. Whereas the
overall proteolytic activity of specific endolysosomal fractions differed substantially, the degradation
patterns of the digested allergens corresponded well. Thus, the protein structure rather than the source
of proteases seemed decisive for antigen processing. Moreover, antigenic peptides showed a good
overlap with previously identified T cell reactive areas. Therefore we suggest that the method might
be used to predict T cell epitopes on allergenic proteins.
Supplementary Materials: Supplementary materials can be found at www.mdpi.com/1422-0067/18/6/1225/s1.
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Abbreviations
ACN Acetonitrile
AEP Asparaginyl endopeptidase
APC Antigen-presenting cell
CD Cluster of differentiation
CLIP Class II-associated invariant chain peptide
DC Dendritic cell
DTT Dithiothreitol
FA Formic acid
FCSi Fetal calf serum (heat inactivated)
GM-CSF Granulocyte macrophage—colony stimulating factor
HLA Human leucocyte antigen
LPS Lipopolysaccharide
MHC Major histocompatibility complex
MS Mass spectrometry
PAGE Polyacrylamide gel electrophoresis
RFU Relative fluorescent unit
SDS Sodium dodecyl sulfate
TFA Trifluoroacetic acid
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